Influencing Factors of Helicobacter Pylori Infection and Eradication Failure
Helicobacter Pylori Infection
About this trial
This is an interventional prevention trial for Helicobacter Pylori Infection focused on measuring Helicobacter pylori, Infection, Risk Factor, Questionnaire
Eligibility Criteria
Inclusion Criteria:
- Perform 13-UBT,
- Be able to understand the content of the questionnaire and answer the questions accurately,
- Permanent residents of Xi'an area,
- No previous HP eradication treatment,
- Agree to join the group and sign the informed consent form,
- Aged between 18-70.
Exclusion Criteria:
- Complicated with serious cardiovascular, respiratory, blood, liver, kidney, nerve or endocrine system diseases,
- Mental disease,
- Gastric or esophageal surgery history,
- Severe atypical hyperplasia of gastric epithelium, gastric malignant tumor or other malignant diseases
- Pregnant or lactating women,
- Patients with history of penicillin allergy,
- Allergy to rabeprazole, bismuth dose, clindamycin,
- Have taken proton pump inhibitors,H2 receptor antagonists, within 2 weeks before participating in the inspection,
- Have taken herbs that have bacteriostatic effect or antibiotic or bismuth agents within 4 weeks before participating in the inspection.
Sites / Locations
- The second affiliated hospital of Xi'an Jiaotong universityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Other
Other
H. pylori negative group
H. pylori positive and successful eradication group
H. pylori positive and eradication failure group
No Intervention
H. pylori-positive patients are given rabeprazole 10mg + amoxicillin 1000mg + clarithromycin 500mg + colloidal bismuth tartrate 220mg bid for 14 days. After 4-6 weeks of completing eradication therapy, 13C-UBT is performed and the result show that H. pylori is eradicated. At the same time, Patients with successful eradication are instructed to conduct 13C-UBT examination after 6 months,1year and every year after drug withdrawal.
H. pylori-positive patients are given rabeprazole 10mg + amoxicillin 1000mg + clarithromycin 500mg + colloidal bismuth tartrate 220mg bid for 14 days. After 4-6 weeks of completing eradication therapy, 13C-UBT is performed and the result show that H. pylori is not eradicated.